Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.2B |
| 3 |
Oracle
ORCL
|
+$945M |
| 4 |
Meta Platforms (Facebook)
META
|
+$913M |
| 5 |
JPMorgan Chase
JPM
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.64B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.16B |
| 3 |
Qualcomm
QCOM
|
+$1.02B |
| 4 |
Tesla
TSLA
|
+$911M |
| 5 |
Mastercard
MA
|
+$837M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.54% |
| 2 | Healthcare | 13.79% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Financials | 10.34% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $39M | ﹤0.01% |
467,972
+1,000
| +0.2% | +$76K |
|
1352
Takeda Pharmaceutical
TAK
$55.7B
| $38.9M | ﹤0.01% |
2,477,403
-15,618
| -0.6% | -$256K |
|
1353
News Corp Class A
NWSA
$15.4B
| $38.9M | ﹤0.01% |
1,993,547
-210,785
| -10% | -$3.82M |
|
|
BRY
1354
DELISTED
Berry Corp
BRY
| $38.8M | ﹤0.01% |
5,639,756
-227
| -0% | -$1.64K |
|
|
DCH
1355
Dauch Corp
DCH
$1.51B
| $38.7M | ﹤0.01% |
4,680,133
-69,078
| -1% | -$512K |
|
1356
Brown & Brown
BRO
$23.9B
| $38.7M | ﹤0.01% |
561,600
-45,944
| -8% | -$2.92M |
|
1357
Green Brick Partners
GRBK
$3.14B
| $38.6M | ﹤0.01% |
680,175
-9,498
| -1% | -$442K |
|
|
PENG
1358
Penguin Solutions Inc
PENG
$2.99B
| $38.5M | ﹤0.01% |
1,328,676
+92,022
| +7% | +$1.84M |
|
1359
ORIX
IX
$43.5B
| $38.4M | ﹤0.01% |
2,107,145
+79,340
| +4% | +$1.38M |
|
1360
Ultragenyx Pharmaceutical
RARE
$2.55B
| $38.4M | ﹤0.01% |
832,677
-171,347
| -17% | -$7.95M |
|
1361
TaskUs
TASK
$669M
| $38.3M | ﹤0.01% |
3,379,985
+639,395
| +23% | +$7.78M |
|
1362
Camden National
CAC
$976M
| $38.1M | ﹤0.01% |
1,228,757
+18,605
| +2% | +$595K |
|
1363
ONE Gas
OGS
$5.04B
| $37.5M | ﹤0.01% |
487,902
-10,180
| -2% | -$813K |
|
1364
Vita Coco
COCO
$3.6B
| $37.2M | ﹤0.01% |
1,384,409
+1,365,498
| +7,221% | +$33.2M |
|
1365
Relay Therapeutics
RLAY
$4.33B
| $37.1M | ﹤0.01% |
2,956,221
-5,850,770
| -66% | -$72.8M |
|
|
SEE
1366
DELISTED
Sealed Air
SEE
| $36.9M | ﹤0.01% |
922,846
-214,523
| -19% | -$9.12M |
|
1367
Aehr Test Systems
AEHR
$3.36B
| $36.7M | ﹤0.01% |
890,763
-55,977
| -6% | -$1.84M |
|
1368
DXC Technology
DXC
$1.73B
| $36.6M | ﹤0.01% |
1,370,287
-437,769
| -24% | -$10.9M |
|
1369
VanEck High Yield Muni ETF
HYD
$4.45B
| $36.6M | ﹤0.01% |
712,726
-25,829
| -3% | -$1.32M |
|
1370
Lloyds Banking Group
LYG
$91.3B
| $36.6M | ﹤0.01% |
16,630,806
-177,704
| -1% | -$407K |
|
1371
Factset
FDS
$10.2B
| $36.6M | ﹤0.01% |
91,283
-9,505
| -9% | -$3.83M |
|
1372
VF Corp
VFC
$5.89B
| $36.5M | ﹤0.01% |
1,911,567
+669,545
| +54% | +$13.7M |
|
|
AMAM
1373
DELISTED
Ambrx Biopharma Inc
AMAM
| $36.4M | ﹤0.01% |
2,210,618
| – | – |
|
1374
iShares Core S&P US Value ETF
IUSV
$27.7B
| $36.2M | ﹤0.01% |
462,671
-1,752
| -0.4% | -$131K |
|
1375
Bank of America Series L
BAC.PRL
$3.99B
| $35.9M | ﹤0.01% |
30,668
-6,456
| -17% | -$7.57M |
|
Similar funds
Fidelity Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Fidelity Investments held 5,715 positions worth $1.19T, up 9.1% from $1.09T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fidelity Investments's Q2 2023 filing shows 467 new, 2,358 increased, 2,086 reduced and 337 closed positions. Its largest new stake was Crane Co: 6,604,359 shares worth $589M. The largest sale was NVIDIA, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2023 buy was Crane Co: 6,604,359 shares worth $589M.
- Fidelity Investments added most to Microsoft in Q2 2023, an estimated $3B increase.
- Fidelity Investments's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $1.64B.
- Fidelity Investments fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $123M.
- Fidelity Investments's ten largest holdings make up 30% of its $1.19T portfolio in Q2 2023.
- Fidelity Investments opened 467 new positions and closed 337 in Q2 2023.
- Fidelity Investments's portfolio value rose 9.1% quarter-over-quarter to $1.19T.
Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.